novo_nordisk_flag

FDA backs Novo’s diabetes drug for cardiovascular efficacy

June 21, 2017
Research and Development Novo Nordisk, Victoza

Good news for Novo Nordisk as the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the FDA recommends that data …

microscope-275984_960_720

FDA-approved drugs in combination could provide new antibiotics

June 21, 2017
Research and Development Antibiotics, FDA, antibiotic resistance

Research emerging from the University of Utah Health has built on knowledge that drugs used in combination can be more …

Novartis receives positive news in eye drug P3 studies

June 20, 2017
Manufacturing and Production, Research and Development Eylea, Novartis, Regeneron

Novartis has achieved positive feedback from its two Phase 3 studies into its eye drug RTH258 (brolucizumab), which found it …

gsk_boronia_australia

GSK’s new President of Global Pharma join date revealed as AZ drops lawsuit

June 20, 2017
Business Services, Manufacturing and Production AZ, AstraZeneca, GSK, GlaxoSmithKline, Luke Miels

The transition of former AstraZeneca Executive Vice President for Europe Luke Miels to rival pharma giant GlaxoSmithKline has not been …

blood-1813410_960_720

‘Vaccine’ to lower cholesterol enters human trials

June 20, 2017
Manufacturing and Production, Research and Development AFFiRis, cholesterol, diabetes

After positive results for a ‘vaccine’ to combat fatty deposits in the arteries in mice, the researchers have taken the …

Pfizer launches vaccine study in Group B Streptococcus

June 20, 2017
Manufacturing and Production, Research and Development Group B Streptococcus, Pfizer

A potentially pivotal Phase 1 study has been launched by Pfizer into the use of its investigational vaccine as a …

entrance_takeda_i020_v1

Merkel opens Takeda’s new production facility in Germany

June 20, 2017
Manufacturing and Production Germany, Takeda, merkel

Angela Merkel was part of the opening ceremony that saw Takeda announce the completion of a third production space in …

Thermo Fisher Scientific announces single quadrupole mass spectrometer and specialised columns

June 19, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Thermo Fisher Scientific Inc., the world leader in serving science, today announced new technologies that are designed to allow analytical …

shutterstock_232245868

Severe asthma patients require more support, Novartis study suggests

June 19, 2017
Research and Development, Sales and Marketing Novartis, asthma

A new study from Novartis has indicated that patients suffering from severe asthma still do not get adequate support to …

shutterstock_95714119

Sudanese research centre launches first-ever mycetoma trial

June 19, 2017
Research and Development, Sales and Marketing mycetoma

A significant step forward has been made in moving towards a treatment for neglected tropical disease mycetoma as the first-ever …

Making strides in hepatitis

June 19, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Janssen, Johnson & Johnson

Pharmafocus caughtup with Lawrence Blatt, Janssen’s Global Therapeutic Area Head, Infectious Diseases and Vaccines, to discuss the progress being made in the …

mosquito

Pulses of light may offer ward against mosquitos

June 19, 2017
Research and Development, Sales and Marketing malaria, mosquito

Research emerging from scientists at the University of Notre Dame has found that exposing mosquitos to light during the night …

shutterstock

First-of-its-kind blood test unlocks precision treatment options for prostate cancer

June 19, 2017
Research and Development, Sales and Marketing

AstraZeneca’s Lynparza (olparib) is making yet another impact following its impressive showing this month in the ovarian cancer space, with …

novartis_window

Novartis receives European biosimilar approval for Roche blockbuster

June 19, 2017
Sales and Marketing Novartis, Rituxan, Rixathon, Roche

Sandoz, a division within Novartis, has received European Commission approval for its biosimilar version of Roche’s Rituxan (also known as …

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 16, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

The weather is heating up as we head into summer, and another week is behind us, meaning another run-down of …

Shooting for the moon: The National Cancer Institute’s Formulary

June 16, 2017
Medical Communications, Research and Development NCI

Pharmafile spoke to National Cancer Institute’s (NCI) Jason Christofaro and Sherry Ansher regarding the development of an agent formulary and its role …

sunbathing-1207930_960_720

Drug that induces tanning could protect against melanoma

June 16, 2017
Medical Communications, Research and Development melanoma, skin cancer, sun

People will often go to extraordinary lengths to achieve tanned skin but researchers have found a potential method that does …

bicycle_therapeutics

Cambridge start-up secures £40 million to trial innovative cancer drugs

June 16, 2017
Medical Communications, Research and Development, Sales and Marketing Bicycle Therapeutics, Cambridge, Cancer

Bicycle Therapeutics, a biotech start-up based in Cambridge, UK, has just raised £40 million from a range of investors including …

fda_sign_web

New rival to EpiPen receives FDA approval to shake up market

June 16, 2017
Medical Communications, Sales and Marketing Adamis, Mylan, Symjepi, epipen

Adamis Pharmaceuticals has revealed that it received FDA approval for its EpiPen rival to enter the market. Its product, to …

roche__tree

From pipeline to patients: Navigating treatments through the UK system

June 15, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, pipeline

Pharmafocus spoke to Karen Lightning-Jones, Integrated Franchise Leader, Pipeline, to discuss the current UK climate for successfully developing drugs to …

The Gateway to Local Adoption Series

Latest content